|
Volumn 23, Issue 2, 2009, Pages 488-489
|
Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
ANGIOGENESIS INHIBITOR;
MONOCLONAL ANTIBODY;
CENTRAL SEROUS RETINOPATHY;
CHRONIC DISEASE;
FLUORESCENCE ANGIOGRAPHY;
HUMAN;
LASER COAGULATION;
LETTER;
OPTICAL COHERENCE TOMOGRAPHY;
PIGMENT EPITHELIUM;
VISUAL ACUITY;
ADULT;
CASE REPORT;
CENTRAL SEROUS CHORIORETINOPATHY;
MALE;
ADULT;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, MONOCLONAL, HUMANIZED;
CENTRAL SEROUS CHORIORETINOPATHY;
CHRONIC DISEASE;
HUMANS;
MALE;
|
EID: 60149083507
PISSN: 0950222X
EISSN: 14765454
Source Type: Journal
DOI: 10.1038/eye.2008.55 Document Type: Letter |
Times cited : (40)
|
References (8)
|